IS5542A - Tríazín efnasambönd til meðhöndlunar á truflunum í miðtaugakerfi (CNS) - Google Patents
Tríazín efnasambönd til meðhöndlunar á truflunum í miðtaugakerfi (CNS)Info
- Publication number
- IS5542A IS5542A IS5542A IS5542A IS5542A IS 5542 A IS5542 A IS 5542A IS 5542 A IS5542 A IS 5542A IS 5542 A IS5542 A IS 5542A IS 5542 A IS5542 A IS 5542A
- Authority
- IS
- Iceland
- Prior art keywords
- cns
- disorders
- treatment
- nervous system
- central nervous
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D253/075—Two hetero atoms, in positions 3 and 5
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9726987.2A GB9726987D0 (en) | 1997-12-22 | 1997-12-22 | Compounds |
| PCT/EP1998/008273 WO1999032462A1 (en) | 1997-12-22 | 1998-12-18 | Triazine compounds for treatment of cns disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS5542A true IS5542A (is) | 2000-06-20 |
Family
ID=10823992
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS5542A IS5542A (is) | 1997-12-22 | 2000-06-20 | Tríazín efnasambönd til meðhöndlunar á truflunum í miðtaugakerfi (CNS) |
Country Status (34)
| Country | Link |
|---|---|
| US (2) | US6265405B1 (is) |
| EP (1) | EP1042304A1 (is) |
| JP (1) | JP2001526275A (is) |
| KR (1) | KR20010024800A (is) |
| CN (1) | CN1284951A (is) |
| AP (1) | AP2000001846A0 (is) |
| AR (1) | AR014146A1 (is) |
| AU (1) | AU753874B2 (is) |
| BR (1) | BR9814495A (is) |
| CA (1) | CA2315620A1 (is) |
| CO (1) | CO5011066A1 (is) |
| EA (1) | EA200000561A1 (is) |
| EE (1) | EE200000391A (is) |
| GB (1) | GB9726987D0 (is) |
| GT (1) | GT199800203A (is) |
| HN (1) | HN1998000193A (is) |
| HR (1) | HRP20000419A2 (is) |
| HU (1) | HUP0100611A3 (is) |
| ID (1) | ID25449A (is) |
| IL (1) | IL136867A0 (is) |
| IS (1) | IS5542A (is) |
| JO (1) | JO2065B1 (is) |
| MA (1) | MA26587A1 (is) |
| NO (1) | NO20003211L (is) |
| NZ (1) | NZ505254A (is) |
| PA (1) | PA8465101A1 (is) |
| PE (1) | PE20000063A1 (is) |
| PL (1) | PL341392A1 (is) |
| SK (1) | SK9592000A3 (is) |
| SV (1) | SV1998000151A (is) |
| TR (1) | TR200001970T2 (is) |
| WO (1) | WO1999032462A1 (is) |
| YU (1) | YU39600A (is) |
| ZA (1) | ZA9811725B (is) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0002666D0 (en) | 2000-02-04 | 2000-03-29 | Univ London | Blockade of voltage dependent sodium channels |
| US6897319B2 (en) * | 2001-12-27 | 2005-05-24 | Ortho-Mcneil Pharmaceutical, Inc. | Useful aroyl pyrrole heteroaryl methanones and methanols |
| CA2493301A1 (en) * | 2002-07-29 | 2004-02-12 | Glaxo Group Limited | Sustained release formulations comprising lamotrigine |
| JP2006515326A (ja) * | 2003-01-30 | 2006-05-25 | ダイノジェン ファーマシューティカルズ， インコーポレイテッド | 胃腸管障害を処置するためのナトリウムチャネルモジュレーターの使用 |
| AR044503A1 (es) | 2003-03-18 | 2005-09-14 | Merck & Co Inc | Triazoles sustituidos con biarilo como bloqueantes del canal de sodio |
| DE10332472A1 (de) * | 2003-07-16 | 2005-02-03 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Ambroxol für die Behandlung von Tinnitus |
| EP1658062B1 (en) * | 2003-08-25 | 2010-02-17 | Newron Pharmaceuticals S.p.A. | Alpha-aminoamide derivatives useful as anti-inflammatory agents |
| US20060115865A1 (en) * | 2004-10-25 | 2006-06-01 | Anlong Ouyang | Lamotrigine analogs |
| GB201111712D0 (en) | 2011-07-08 | 2011-08-24 | Gosforth Ct Holdings Pty Ltd | Pharmaceutical compositions |
| ES2770143T3 (es) * | 2018-02-13 | 2020-06-30 | Fis Fabbrica Italiana Sintetici Spa | Nuevo procedimiento eficiente para la preparación de sitagliptina |
| CN114796146B (zh) * | 2022-04-28 | 2023-03-28 | 上海奥科达医药科技股份有限公司 | 一种拉莫三嗪的缓释制剂及其制备方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3637688A (en) | 1970-01-09 | 1972-01-25 | American Home Prod | 6-(fluoro and trifluoromethyl phenyl)-3 5-diamino - 1 2 4 - triazines and substituted - 6 - phenylalkyl-3,5-diamino-1 2 4-triazines |
| DE3062603D1 (en) | 1979-06-01 | 1983-05-11 | Wellcome Found | 3,5-diamino-1,2,4-triazine derivatives, process for preparing such compounds and pharmaceutical compositions containing them |
| ZA803250B (en) * | 1979-06-01 | 1982-01-27 | Wellcome Found | Substituded aromatic compounds |
| IT1145308B (it) | 1979-08-16 | 1986-11-05 | Wellcome Found | Composti aromatici sostituiti |
| GB8328757D0 (en) | 1983-10-27 | 1983-11-30 | Wellcome Found | Chemical compounds |
| GB9012312D0 (en) | 1990-06-01 | 1990-07-18 | Wellcome Found | Pharmacologically active cns compounds |
| GB9012316D0 (en) | 1990-06-01 | 1990-07-18 | Wellcome Found | Pharmacologically active cns compounds |
| GB9012311D0 (en) | 1990-06-01 | 1990-07-18 | Wellcome Found | Pharmacologically active cns compounds |
| GB9203483D0 (en) | 1992-02-19 | 1992-04-08 | Wellcome Found | Anti-inflammatory compounds |
| SK279730B6 (sk) | 1992-06-12 | 1999-02-11 | The Wellcome Foundation Ltd | Iazínu a jehofarmaceuticky a veterinárne prijateľn |
| WO1994014780A1 (en) | 1992-12-18 | 1994-07-07 | The Wellcome Foundation Limited | Pyrimidine, pyridine, pteridinone and indazole derivatives as enzyme inhibitors |
| US5866597A (en) | 1993-03-19 | 1999-02-02 | Glaxo Wellcome Inc. | Use of triazine compounds for the treatment of memory and learning disorders |
| GB9305692D0 (en) | 1993-03-19 | 1993-05-05 | Wellcome Found | Therapeutic triazine compounds and use |
| GB9426448D0 (en) * | 1994-12-30 | 1995-03-01 | Wellcome Found | Process |
| FR2741879A1 (fr) | 1995-12-05 | 1997-06-06 | Esteve Labor Dr | Derives de fluorophenyl-triazines et pyrimidines, leur preparation et leur application en tant que medicament |
-
1997
- 1997-12-22 GB GBGB9726987.2A patent/GB9726987D0/en not_active Ceased
-
1998
- 1998-12-18 HU HU0100611A patent/HUP0100611A3/hu unknown
- 1998-12-18 KR KR1020007006947A patent/KR20010024800A/ko not_active Application Discontinuation
- 1998-12-18 SV SV1998000151A patent/SV1998000151A/es unknown
- 1998-12-18 ID IDW20001416A patent/ID25449A/id unknown
- 1998-12-18 JP JP2000525399A patent/JP2001526275A/ja active Pending
- 1998-12-18 WO PCT/EP1998/008273 patent/WO1999032462A1/en not_active Application Discontinuation
- 1998-12-18 CO CO98075403A patent/CO5011066A1/es unknown
- 1998-12-18 SK SK959-2000A patent/SK9592000A3/sk unknown
- 1998-12-18 EA EA200000561A patent/EA200000561A1/ru unknown
- 1998-12-18 YU YU39600A patent/YU39600A/sh unknown
- 1998-12-18 EP EP98966635A patent/EP1042304A1/en not_active Withdrawn
- 1998-12-18 NZ NZ505254A patent/NZ505254A/en unknown
- 1998-12-18 EE EEP200000391A patent/EE200000391A/xx unknown
- 1998-12-18 CN CN98813745A patent/CN1284951A/zh active Pending
- 1998-12-18 AP APAP/P/2000/001846A patent/AP2000001846A0/en unknown
- 1998-12-18 PL PL98341392A patent/PL341392A1/xx unknown
- 1998-12-18 AR ARP980106526A patent/AR014146A1/es not_active Application Discontinuation
- 1998-12-18 CA CA002315620A patent/CA2315620A1/en not_active Abandoned
- 1998-12-18 AU AU24147/99A patent/AU753874B2/en not_active Ceased
- 1998-12-18 IL IL13686798A patent/IL136867A0/xx unknown
- 1998-12-18 TR TR2000/01970T patent/TR200001970T2/xx unknown
- 1998-12-18 US US09/582,058 patent/US6265405B1/en not_active Expired - Fee Related
- 1998-12-18 BR BR9814495-2A patent/BR9814495A/pt not_active IP Right Cessation
- 1998-12-21 JO JO19982065A patent/JO2065B1/en active
- 1998-12-21 PE PE1998001255A patent/PE20000063A1/es not_active Application Discontinuation
- 1998-12-21 PA PA19988465101A patent/PA8465101A1/es unknown
- 1998-12-21 ZA ZA9811725A patent/ZA9811725B/xx unknown
- 1998-12-22 MA MA25403A patent/MA26587A1/fr unknown
- 1998-12-22 GT GT199800203A patent/GT199800203A/es unknown
-
1999
- 1999-12-21 HN HN1998000193A patent/HN1998000193A/es unknown
-
2000
- 2000-06-20 IS IS5542A patent/IS5542A/is unknown
- 2000-06-21 NO NO20003211A patent/NO20003211L/no unknown
- 2000-06-21 HR HR20000419A patent/HRP20000419A2/hr not_active Application Discontinuation
-
2001
- 2001-07-06 US US09/899,198 patent/US6465461B1/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS5113A (is) | Notkun antagónista CB1-viðtaka til meðhöndlunar löngunartruflana | |
| PL339860A1 (en) | Methods of modulating the action of serine/threonine protein kinase by means of compounds based on 5-azaquinoxaline | |
| DK0769947T3 (da) | Indolinonforbindelser til behandling af sygdom | |
| IS6003A (is) | Mónóamín endurupptökulatar til meðhöndlunar á truflunum í miðtaugakerfi | |
| NO994689D0 (no) | Fremgangsmaate til aa diagnostisere psykiatriske lidelser | |
| IS5085A (is) | Nefholssamsetningar til meðhöndlunar á kynferðistruflunum | |
| NO972869D0 (no) | Fremgangsmåte for fremstilling av höyrent melamin | |
| NO20002951D0 (no) | FremgangsmÕte til gjenvinning av olefiner | |
| IS5542A (is) | Tríazín efnasambönd til meðhöndlunar á truflunum í miðtaugakerfi (CNS) | |
| NO20012285D0 (no) | Fremgangsmåte til fremstilling av rent melamin | |
| DK1105390T3 (da) | Imidazo(1,2a)pyridinderivater til behandling af gastrointestinale sygdomme | |
| NO20000788D0 (no) | Fremgangsmåte for fremstilling av aromatiske aminer | |
| DK1053217T3 (da) | Fremgangsmåde til fremstilling af n-propanol | |
| ID27214A (id) | Triazolopiridina untuk pengobatan gangguan trombosis | |
| DK1008558T3 (da) | Fremgangsmåde til behandling af organisk spildevand | |
| DK0946514T3 (da) | Fremgangsmåde til fremstilling af n-substituerede 3-hydroxypyrazoler | |
| DK0935598T3 (da) | 5-heteroatom-alkylsubstituerede 3-oxopyrido(1,2-a)benzimidazol-4-carboxamidderivater egnede til behandling af sygdomme i centralnervesystemet | |
| NO991734D0 (no) | Pyrazolinoner for behandling av potensforstyrrelser | |
| HUP0004030A3 (en) | Process for the purification of aspartame derivative | |
| DK1121356T3 (da) | 3-tetrahydropyridin-4-yl-indoler til behandling af psykotiske lidelser | |
| IS6098A (is) | Ósantant til meðhöndlunar á skaptruflunum | |
| ID21920A (id) | 4-6-fluoro-(1h)-indol-3-il-1,2,3,6-tetrahidropirin tersubstitusi untuk pengobatan gangguan cns | |
| DK1011678T3 (da) | Anvendelse af mecamylamin til behandling af nikotin-responsive neuropsykiatriske lidelser | |
| DK0729959T3 (da) | Fremgangsmåde til fremstilling af loracarbefmonohydrat | |
| DK0964681T3 (da) | Antikonvulsive derivater til behandling af psoriasis |